BibTex RIS Cite

Çocuklarda Dilate Kardiyomiyopati

Year 2005, Volume: 3 Issue: 2, 70 - 73, 01.09.2005

Hülya Köse Ergün Çil

Abstract

Dilate kardiyomiyopati, en sık görülen kardiyomiyopati tipi olup; günümüzde kalp nakli uygulanan hastaların önemli bir kısmını oluşturması açısından önemli bir sağlık sorunudur. Dilate kardiyomiyopati, sol veya her iki ventrikülün dilatasyonu ve azalmış kontraksiyonu ile karakterizedir. idiopatik, genetik, viral, immün, toksik nedenli olabileceği gibi, mevcut miyokardiyal yüklenme veya iskemi bulguları ile açıklanamayacak düzeyde miyokardiyal disfonksiyon gösteren diğer kardiyovasküler hastalıklarda da görülebilir.

References

  • 1. Kasper EK, Agema WRP, Hutchins GM, et al. The causes of dilated car￾diomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23:586-90.
  • 2. Manolio TA, Baugman KL, Rodeheffer R, et al. Prevelance and etiology of idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1458-66.
  • 3. Bilgiç A, Özbarlas N, Özkutlu S, et al. Cardiomyophaties in children: Cli￾nical, epidemiological and prognostic evaluation. Jpn Heart J. 1990; 31:789-97.
  • 4. Venugopalan P, Agarwal AK, Worthing A. Chronic cardiac failure in children due to dilated cardiyomyopathy: Diagnostic approach, pathophsiology and management. Eur J Pediatr. 2000;159:803-10. Review. Erratum in: Eur J Pediatr 2001; 160:266.
  • 5. Ishikawa Y, Bach JR, Minami R, et al. Cardioprotectin for Duchenne’s muscular dystrophy. Am Heart J 1999; 137:895-902.
  • 6. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human _-sarcog￾lican gene in familial and sporadic dilated cardiyomyopathy. J Clin Invest 2000; 106:655-62.
  • 7. Marin-Garcia J, Ananhakrishnan R, Godenthal MJ, et al. Mitokondrial dysfunction in sceletal muscle of children with cardiomyopathy. Pediatrics 1999; 103:456-9.
  • 8. Constantinos J, Irvin F. Soluble interleukin-2 reseptor levels in patients with dilated cardiomyoapthy. Circulation. 1995; 91:631-4.
  • 9. Pierpont MAM, Breningstall GN, Stanley CA, et al. Familial carnitine transporter defect: A treatable cause of cardiyomyopathy in children. Am Heart J 2000; 139:96-106.
  • 10. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-sta￾ge heart failure. N Eng J Med 1996; 335:1182-9.
  • 11. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Eng J Med 1994; 331:1564-75.
  • 12. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the failing heart. A new area in the treatment of failure. Circulation 1996;94:2285-96.
  • 13. Rodhey SM, Rathiff NB, Young JB. Cardiomyopathy and myocardial fa￾ilure. In: Califf RM, Isner JM, et al (eds) Textbook of Cardiovascular Medicine. Philadelphia, Lippincott-Raven 1997; pp:2215-46.
  • 14. Friedman RA, Moak JP, Garson A. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991; 18:152-6.
  • 15. Pfefeir MA. Angiotensin converting enzyme inhibition in congestive he￾art failure: Benefit and perspective. Am Heart J 1993; 126:789-93.
  • 16. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Bris￾tow MR. Comperative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the falling heart. Circulation 1996; 94:2817-25.
  • 17. Spicer R. Carvedilol -a new dimension in pediatric heart failure therapy. J Pediatr 2001; 138:457-8.
  • 18. Flesch M, Maack C, Cremers B, Baumer AT, Sudkamp M, Bohm M. Ef￾fect of beta blockers on free radical induced cardiac contractile dysfunction. Circulation 1999; 100:346-53.
  • 19. Bruns CM, Lamour J et al: Carvedilol as therapy in pediatric heart failu￾re. Am Heart J 2002; 143:916-22.
  • 20. Robert A, Edward M. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or isc￾hemic cardiomyopathy. Am J Cardiol 1996; 78:779-84.
  • 21. Christophe M, Philippe A, Daniel S. Use of 123 I-MIBG scintigraphy to as￾sess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2003; 30:1651-6.
  • 22. Stephanie L, Thomas S. Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters. Am Heart J 2002; 143:916-22.
  • 23. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Cardiol 1988; 11:139-44.
  • 24. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 1991; 68:365-9.
  • 25. Chen SC, Nouri S, Balfour I, et al. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 1990; 15:189-93.
  • 26. Taliercio CO, Seward JB, Driscoll DJ, et al. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Car￾diol 1985; 6:1126-31.
  • 27. Akagi T, Benson LN, Lightfoot NE, et al. Natural history of dilated cardiomyopathy in children. Am Heart J 1991; 121:1502-6

Year 2005, Volume: 3 Issue: 2, 70 - 73, 01.09.2005

Hülya Köse Ergün Çil

Abstract

References

  • 1. Kasper EK, Agema WRP, Hutchins GM, et al. The causes of dilated car￾diomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23:586-90.
  • 2. Manolio TA, Baugman KL, Rodeheffer R, et al. Prevelance and etiology of idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69:1458-66.
  • 3. Bilgiç A, Özbarlas N, Özkutlu S, et al. Cardiomyophaties in children: Cli￾nical, epidemiological and prognostic evaluation. Jpn Heart J. 1990; 31:789-97.
  • 4. Venugopalan P, Agarwal AK, Worthing A. Chronic cardiac failure in children due to dilated cardiyomyopathy: Diagnostic approach, pathophsiology and management. Eur J Pediatr. 2000;159:803-10. Review. Erratum in: Eur J Pediatr 2001; 160:266.
  • 5. Ishikawa Y, Bach JR, Minami R, et al. Cardioprotectin for Duchenne’s muscular dystrophy. Am Heart J 1999; 137:895-902.
  • 6. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human _-sarcog￾lican gene in familial and sporadic dilated cardiyomyopathy. J Clin Invest 2000; 106:655-62.
  • 7. Marin-Garcia J, Ananhakrishnan R, Godenthal MJ, et al. Mitokondrial dysfunction in sceletal muscle of children with cardiomyopathy. Pediatrics 1999; 103:456-9.
  • 8. Constantinos J, Irvin F. Soluble interleukin-2 reseptor levels in patients with dilated cardiomyoapthy. Circulation. 1995; 91:631-4.
  • 9. Pierpont MAM, Breningstall GN, Stanley CA, et al. Familial carnitine transporter defect: A treatable cause of cardiyomyopathy in children. Am Heart J 2000; 139:96-106.
  • 10. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-sta￾ge heart failure. N Eng J Med 1996; 335:1182-9.
  • 11. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Eng J Med 1994; 331:1564-75.
  • 12. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the failing heart. A new area in the treatment of failure. Circulation 1996;94:2285-96.
  • 13. Rodhey SM, Rathiff NB, Young JB. Cardiomyopathy and myocardial fa￾ilure. In: Califf RM, Isner JM, et al (eds) Textbook of Cardiovascular Medicine. Philadelphia, Lippincott-Raven 1997; pp:2215-46.
  • 14. Friedman RA, Moak JP, Garson A. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 1991; 18:152-6.
  • 15. Pfefeir MA. Angiotensin converting enzyme inhibition in congestive he￾art failure: Benefit and perspective. Am Heart J 1993; 126:789-93.
  • 16. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Bris￾tow MR. Comperative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the falling heart. Circulation 1996; 94:2817-25.
  • 17. Spicer R. Carvedilol -a new dimension in pediatric heart failure therapy. J Pediatr 2001; 138:457-8.
  • 18. Flesch M, Maack C, Cremers B, Baumer AT, Sudkamp M, Bohm M. Ef￾fect of beta blockers on free radical induced cardiac contractile dysfunction. Circulation 1999; 100:346-53.
  • 19. Bruns CM, Lamour J et al: Carvedilol as therapy in pediatric heart failu￾re. Am Heart J 2002; 143:916-22.
  • 20. Robert A, Edward M. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or isc￾hemic cardiomyopathy. Am J Cardiol 1996; 78:779-84.
  • 21. Christophe M, Philippe A, Daniel S. Use of 123 I-MIBG scintigraphy to as￾sess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2003; 30:1651-6.
  • 22. Stephanie L, Thomas S. Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters. Am Heart J 2002; 143:916-22.
  • 23. Griffin ML, Hernandez A, Martin TC, et al. Dilated cardiomyopathy in infants and children. J Am Cardiol 1988; 11:139-44.
  • 24. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 1991; 68:365-9.
  • 25. Chen SC, Nouri S, Balfour I, et al. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 1990; 15:189-93.
  • 26. Taliercio CO, Seward JB, Driscoll DJ, et al. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Car￾diol 1985; 6:1126-31.
  • 27. Akagi T, Benson LN, Lightfoot NE, et al. Natural history of dilated cardiomyopathy in children. Am Heart J 1991; 121:1502-6
There are 27 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Hülya Köse This is me

Ergün Çil

Publication Date September 1, 2005
Published in Issue Year 2005 Volume: 3 Issue: 2

Cite

APA Köse, H., & Çil, E. (2005). Çocuklarda Dilate Kardiyomiyopati. Güncel Pediatri, 3(2), 70-73.
AMA Köse H, Çil E. Çocuklarda Dilate Kardiyomiyopati. Güncel Pediatri. September 2005;3(2):70-73.
Chicago Köse, Hülya, and Ergün Çil. “Çocuklarda Dilate Kardiyomiyopati”. Güncel Pediatri 3, no. 2 (September 2005): 70-73.
EndNote Köse H, Çil E (September 1, 2005) Çocuklarda Dilate Kardiyomiyopati. Güncel Pediatri 3 2 70–73.
IEEE H. Köse and E. Çil, “Çocuklarda Dilate Kardiyomiyopati”, Güncel Pediatri, vol. 3, no. 2, pp. 70–73, 2005.
ISNAD Köse, Hülya - Çil, Ergün. “Çocuklarda Dilate Kardiyomiyopati”. Güncel Pediatri 3/2 (September 2005), 70-73.
JAMA Köse H, Çil E. Çocuklarda Dilate Kardiyomiyopati. Güncel Pediatri. 2005;3:70–73.
MLA Köse, Hülya and Ergün Çil. “Çocuklarda Dilate Kardiyomiyopati”. Güncel Pediatri, vol. 3, no. 2, 2005, pp. 70-73.
Vancouver Köse H, Çil E. Çocuklarda Dilate Kardiyomiyopati. Güncel Pediatri. 2005;3(2):70-3.